We examined the impact of Massachusetts insurance reform on the care of women at six community health centers with abnormal breast and cervical cancer screening to investigate whether stability of insurance coverage was associated with more timely diagnostic resolution. We conducted Cox proportional hazards models to predict time from cancer screening to diagnostic resolution, examining the impact of 1) insurance status at time of screening abnormality, 2) number of insurance switches over a three-year period, and 3) insurance history over a three-year period. We identifi ed 1,165 women with breast and 781 with cervical cancer screening abnormalities. In the breast cohort, Medicaid insurance at baseline, continuous public insurance, and losing insurance predicted delayed resolution. We did not fi nd these eff ects in the cervical cohort. Th ese data provide evidence that stability of health insurance coverage with insurance reform nationally may improve timely care aft er abnormal cancer screening in historically underserved women.
to low-income and minority groups will result in better access, better continuity of care, and better outcomes of care. Th ere is a need for research to investigate the impact that the implementation of broader insurance coverage has on health within specifi c populations, especially those with documented disparities.
One mechanism by which insurance reform may improve health outcomes is by reducing not only the rate of uninsurance but also the instability in health insurance coverage. We defi ne insurance instability in this paper as switches in insurance coverage or loss of coverage. Whereas there is an extensive literature [1] [2] [3] [4] [5] [6] [7] [8] on the negative impact of lacking insurance on a variety of health outcomes, fewer studies have examined the impact of insurance instability. On the other hand, one of the concerns with the implementation of this legislation is its potential for gaps or even losses in coverage that can disrupt health care delivery. Small changes in income could shift eligibility between government-subsidized and non-subsidized plans as one potential form of instability. 9, 10 One way to evaluate the impact of insurance coverage and switches across a population is to identify a cohort of vulnerable patients with similar health utilization needs. One such group is women with abnormal breast and cervical cancer screening tests in need of diagnostic resolution. Cancer screening will only be eff ective if a woman with an abnormal test completes diagnostic follow-up in a suffi ciently timely fashion in order to identify cancer early. Delays in diagnosis and treatment as little as three months have been shown to increase breast cancer recurrence 4, 11 and reduce survival rates; these delays are more common among vulnerable populations (defi ned by racial/ ethnic minority or low income status). 12, 13 Research to date 14 has not examined the impact of switches or gaps in health insurance coverage for the outcome of diagnostic resolution.
In order to examine the impact of health insurance reform on diagnostic resolution aft er abnormal cancer screening, we conducted a secondary analysis of data from a study that spanned the time period of pre-and post-health insurance reform in the state of Massachusetts. Massachusetts health insurance reform included several approaches to provide near universal coverage. Th ese included expansion of Medicaid, an individual mandate, a mandate for employers with 10 or more employees to provide premium support, and the development of the health insurance exchange called the Health Connector which connects consumers to two programs. Th e fi rst, Commonwealth Care, provides subsidized insurance coverage for people with incomes up to 300% of the federal poverty line. Th e other, Commonwealth Choice, is a commercial insurance program available to small employers and individuals who do not qualify for subsidies. Th is study includes a cohort of minority and low-income women, i.e., women from groups whose members oft en do not have health insurance and are most susceptible to its loss when they do have it. We hypothesized that insurance instability, defi ned as switches in health insurance coverage including loss of coverage, would be associated with slower diagnostic resolution.
Methods
Population and eligibility. We conducted a secondary analysis of subjects included in the control arm of the Boston Patient Navigation Research Program (PNRP) 15 which was designed to test the ability of a patient navigation intervention to improve timely diagnostic care in vulnerable populations. Th e population included women with abnormal breast or cervical cancer screening tests at six community health centers, fi ve which are federally qualifi ed, serving an urban population of women representing diverse racial, income, and insurance payer backgrounds. We included women over 18 years of age with a breast or cervical cancer screening abnormality at one of six participating community health centers, from the control arm of PNRP, which received usual care. We included a random subset of up to 100 subjects from each health center from 2004-2005 (pre-reform) and all subjects with abnormal screening from 2007-2008 (post-reform) .
Th e specifi c breast cancer screening abnormalities we included were abnormal mammograms, ultrasound or magnetic resonance imaging (MRI) coded according to the Breast Imaging Reporting and Data System (BIRADS), 16 with scores corresponded with radiographic fi ndings of lesions which were incomplete (BIRADS 0), probably benign (BIRADS 3), suspicious abnormality (BIRADS 4), or highly suspicious of malignancy (BIRADS 5), respectively. Abnormal clinical breast examinations with a mass or other lesion suspicious for cancer were additional eligibility criteria for entry into the study. Cervical cancer screening abnormalities included Pap test fi ndings of low and highgrade squamous intraepithelial lesions (LGSIL and HGSIL), atypical cells of unknown signifi cance (ASCUS) when refl ex testing for high-risk human papilloma virus (HPV) was positive, or atypical glandular cells of unknown signifi cance (AGUS). We excluded women who were pregnant at the time of screening as pregnancy may alter the time course for diagnostic procedures. We also excluded women with cognitive diffi culties and major psychiatric diagnoses who may have been unable to participate in the navigation intervention (as part of the parent study). 15 Lastly, we excluded people with less than one month of care at the health center, as we were unable to assess longitudinal insurance coverage.
Outcome. We collected all clinical and demographic data through the electronic medical records at each of the health centers. We abstracted race/ ethnicity information from a single variable item categorized as White, Black, Hispanic, Asian, and other; prior research has demonstrated high concordance, with kappa values between 81% and 91% comparing these registration data with self-reported race and ethnicity. 17 We imputed race/ ethnicity for 8% of subjects where registration data was missing, using the following items in hierarchical order: providers' notes in the medical record, primary language, country of origin, or the patient's surname. 18, 19 We imputed approximately 6% of records for language preference "other than English" if there was documentation of another language in the medical record, need for interpreter, or a result letter sent to the patient in a language other than English. Th e electronic charts we reviewed captured all screening studies and their results. We collected all subsequent information on the clinical diagnostic evaluation, including tests ordered and their results, through manual abstraction by trained abstractors. We abstracted 10% of records in duplicate for reliability assessment. 15 As in the parent study, we measured time to diagnostic resolution as the number of days from screening to diagnostic resolution. In women with cervical cancer screening abnormalities, diagnostic resolution included colposcopy with or without biopsy or physician determination that colposcopy was not indicated. For women with breast screening abnormalities, diagnostic resolution included additional imaging, biopsy, or clinical examination by a breast health physician making a determination that no abnormality was present. For subjects eligible because of a BIRADS 3 result, where radiologists recommend follow-up in several six month intervals to check for changes, we measured date of diagnostic resolution beginning six months from the date of the index abnormality to the next imaging studies (which is consistent with our approach in prior work).
15
Health insurance coverage variables. In order to defi ne health insurance status, we manually abstracted billing reimbursement data for each woman 18 months before through 18 months aft er her index abnormal cancer screening, coding type of insurance coverage for the date of the abnormal screening test, and the date of care and type of coverage for all visits with a switch in insurance coverage. Using these data, we created four health insurance coverage variables as predictors of time to diagnostic resolution. Th ey are described below.
1)
Index insurance status at time of screening abnormality. 2) Number of insurance switches over the 36 months of observation. We defi ned an insurance switch as a change from one of fi ve major types of insurance categories (private (including Commonwealth Choice), Medicare, Commonwealth Care, Medicaid, or uninsured) to another. If subjects had more than one type of coverage, we assigned the principal insurance category based on the following hierarchy ranked upon our hypothesized decreasing comprehensiveness of coverage: private insurance, Medicare, Commonwealth Care, Medicaid, and uninsured. We categorized individuals as having no, one, or two or more switches. 3) Insurance coverage history. Because the latter categorized those continuously insured and those never insured into the same group, we also defi ned insurance histories into fi ve mutually exclusive categories: "always private" for those maintaining continuous private/ commercial insurance; "always public" for those maintaining continuous coverage with either Medicaid or Medicare; "one or more switches, never uninsured" for those with one or more insurance switches during the 36 months of observation but never uninsured; "one or more switches uninsured" for any subject losing coverage at some point in the 36 months; and "always uninsured. Analysis. We analyzed women with abnormal breast and cervical cancer screening separately, due to diff erent courses of diagnostic evaluation, and diff erences in age and racial/ ethnic distribution in each group. We calculated descriptive statistics to report socio-demographic characteristics of the two study populations and to characterize the time to resolution in each population. We then constructed a series of Cox proportional hazard models to identify the independent eff ect of health insurance status on time to resolution, adjusting for age, race/ ethnicity, and language and clustering by facility. Due to violations in the proportion hazards, we included an interaction term for time in the models, and report separate adjusted hazards ratios for 0-60 days of follow up and 61-365 days of follow-up. 20, 21 We performed all analyses in SAS 9.2.
22 Th e Boston University Medical Center Institutional Review Board and Boston HealthNet Research Subcommittee (the organization that reviews studies that involve community health centers affi liated with Boston Medical Center) approved this study.
Results
We included 1,946 women in our analysis, 434 from the pre-reform period and 1,512 from the post-reform period. We excluded 46 women (2.3%) who either had no billing data available, or who were in care at the health center for less than one month during the time of study. Women with abnormal breast cancer screening were in care for a mean of 26 (standard deviation SD = 9.1) months, and had a mean of 18 days in clinical care during that time. Women with abnormal cervical cancer screening had a mean of 15 days in clinical care over a mean of 23 (SD = 9.5) months. Th is long-term use of care at the health center allowed us to observe changes in insurance coverage over time. Table 1 presents subject characteristics by type of cancer screening (breast or cervical) and by time period (pre-or post-reform). Th e mean age of women with abnormal breast and cervical cancer screening was 52 years (SD 11 years) and 28 years (SD 9 years), respectively. Th e population was racially and ethnically diverse; 35% of women were White, 32% were Black, and 28% were Hispanic; 66% spoke English as their primary language and 18% were Spanish-speaking. Th ere are also signifi cant changes over time in race/ ethnicity and primary language between the pre-and post-reform time periods, refl ecting temporal changes in the communities cared for at the health centers. Th ere were signifi cantly fewer uninsured subjects with abnormal breast cancer screening in the post-reform era compared with the pre-reform era (42% vs. 33%) (p = .009). In women with cervical cancer screening abnormalities, the proportion uninsured in the post-reform period diminished to half of the pre-reform level (36% to 18%). Table 2 demonstrates the unadjusted association between insurance status and time to resolution at 60 and 365 days of follow-up. Privately insured women had the highest rates of resolution at both 60 and 365 days for breast screening abnormalities. Women with Medicaid insurance had the lowest rates of cervical screening resolution at 60 days, but this gap narrowed by 365 days. Th e number of switches did not aff ect time to resolution. Looking at insurance histories, women in continuous public or those uninsured in general had more delays than those with continuous private coverage. We did not fi nd an overall eff ect before and aft er insurance reform on time to resolution for the entire group under study. Table 3 provides the four health insurance coverage variables and hazards ratios adjusted for age, race/ ethnicity, language and clustering by facility. Our analysis yielded the following fi ndings. Within the cervical screening abnormalities none of the insurance coverage variables predicted time to resolution adjusted for socio-demographic characteristics. Within the breast cancer cohort, insurance coverage did show several eff ects. Having Medicaid insurance (HR = 0.72 95% CI 0.60-0.88) or no insurance (HR 0.80, 95% CI 0.68-0.95) at the time of abnormal breast cancer screening was associated Table 1 . 130 (56) 265 (48) 398 (20) 26-35 years 2 (1) 5 (1) 66 (29) 186 (34) 259 (13) 36-45 years 57 (28) 335 (35) 22 (10) 71 (13) 485 (25) 46-55 years
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Discussion
We developed a series of measures to analyze insurance coverage, stability, and reform for their impact on diagnostic resolution of cancer screening abnormalities among a vulnerable population of women seeking care at urban community health centers. We found that insurance coverage and stability of insurance coverage were predictors of timelier follow-up care for women with abnormal breast cancer screening but not for women with abnormal cervical cancer screening. Having Medicaid or no insurance at baseline and losing insurance coverage were associated with slower rates of diagnostic resolution compared with having private insurance and stable coverage, respectively. Comparing our entire cohort before and aft er insurance reform, we did not fi nd any change in time to resolution for the entire population. We found that diagnostic resolution rates were generally quite high aft er abnormal breast cancer screening and somewhat lower aft er abnormal cervical cancer screening. Although the impact of insurance instability has been documented primarily in the pediatric literature, a few reports [5] [6] [7] have demonstrated its negative eff ect in adults. Authors of a 2008 systematic review 14 identifi ed seven studies examining the impact of gaining and losing health insurance on health care utilization. Th ey found increased use of preventive and primary care with the gain of insurance. Other research 8 has demonstrated that gaps in insurance coverage are linked to a lack of continuity in prescription refi lls. Gold and colleagues 4 measured the eff ect of continuous and intermittent lack of insurance on quality indicators for diabetic patients receiving care from a federally qualifi ed health clinic practice network. Th ose continuously and intermittently uninsured were less likely to have up-to-date glycosylated hemoglobin measurement, lipid testing, renal function assessment, or infl uenza vaccination. Bindman and colleagues 23 found that interruption in Medicaid coverage was associated with a 3.7-fold increase in ambulatory care sensitive hospitalizations compared with benefi ciaries continuously insured.
Our fi ndings that interruptions in insurance coverage result in delays in care are noteworthy in that diagnostic resolution required a short-term set of clinical activities. For many women it required one additional visit for imaging. At most it required three or four visits in order to obtain a biopsy and tissue diagnosis. Th is is in contrast to chronic disease management, which requires ongoing surveillance and behavioral management to aff ect outcomes. Our fi nding of delayed diagnostic resolution among subjects losing insurance with breast but not with cervical screening abnormalities may relate to diff erences in location of health care delivery. All health centers conducted colposcopy on site, whereas none provided diagnostic imaging for breast care. For diagnostic breast care, a patient must go to a new care site, typically to a hospital, which would require insurance coverage for registration. For patients with lapsed insurance needing follow-up of an abnormal breast cancer screening result, days of delay would result. In comparison, the health centers had a policy of seeing patients once the appointment was made, and lapses of coverage would therefore not delay care. Th e lack of an impact aft er losing insurance coverage for follow-up aft er abnormal cervical cancer screening may also relate to Title X Family Planning Act funding. 24 Th is covered abnormal Pap smear follow-up at the health centers, thus providing coverage for uninsured patients to receive colposcopy as part of reproductive care, whereas Title X funding did not cover evaluation of breast abnormalities. Our fi nding of the diff erence between breast and cervical cohorts may therefore be related to the additional benefi ts to women of the Title X funding, providing gap coverage and preventing delays in care.
Th ey are several limitations to our study. We were only able to determine switches associated with utilization of care. If someone did not use care during an uninsured gap, we would not have identifi ed this switch into the uninsured state. Because we relied on health center data to determine subsequent care utilization, we may have missed utilization that occurred at other health care facilities. For example, if individuals covered by private insurance obtained diagnostic care at another health care institution, we would not have this information and would code this as a delay in diagnostic care. If this occurred, it would bias our results toward no diff erence between those continuously insured and those with gaps in coverage. Linking our data with enrollment fi les would assist in our understanding of gaps and switches in insurance. Movements to create state-level, all payer outpatient datasets 25 may facilitate reconciling this methodologic limitation in the future. Data from this study and other work 26 indicate that patients receiving care at our health centers continue to return even with changes in health insurance. Moreover, the fact that we detected an association for switches into an uninsured state despite this potential under ascertainment argues for the credibility of our fi nding. Unlike the authors of the Bindman study, 23 we were able to capture insurance coverage that was retroactively reinstated by looking retrospectively at paid claims. In addition, we examined screening outcomes exclusively in a population of women receiving care by safety-net providers. Our fi ndings may not generalize to patients outside a safety-net care system, or to women without a usual source of primary care.
Our study has important implications. Th e impact of being uninsured and losing insurance is signifi cant even in our context of short-term follow-up care. Our results speak to the need for full implementation of the Aff ordable Care Act, including Medicaid expansion into all states to ensure that patients who complete screening programs have the resources available to address abnormal screening fi ndings. Th e absence of an eff ect for switches between public and private categories of insurance coverage is reassuring for the proposed changes, given that a subset of the population will likely undergo switches in coverage through employment and income changes. Lastly our data suggest that safety-net programs, such as Title X, may continue to play a critical role for underserved women in ensuring access to needed care even during insurance gaps.
